Product Information

ALFUZOSIN HCL ER 10 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.1077 per EA under NDC 60505285009. Its NADAC has been published 150 times since Oct 11, 2023.

FDA first approved this application on Jul 18, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ALFUZOSIN HCL ER 10 MG TABLET

Alfuzosin Hydrochloride
$0.1077per EA

Strength

10 mg/1

Manufacturer

Apotex Corp.

NDC

60505285009

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ALFUZOSIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA079013

FDA Approved

7/18/2011

TE Code

AB

On Market Since

9/8/2023

Pharmacological Classes

Adrenergic alpha-Antagonists
alpha-Adrenergic Blocker

Price Statistics

The NADAC for ALFUZOSIN HCL ER 10 MG TABLET has been published 150 times since Oct 11, 2023, and over the history we have for it it has declined 4.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1077 per EA
All-time high$0.1516 (Dec 13, 2023)
All-time low$0.1034 (Jan 22, 2025)
52-week high$0.1121
52-week low$0.1052
Median price$0.1091
Average price$0.1126
Largest weekly change+32.0% (Nov 22, 2023)
Weeks tracked150
Tracking sinceOct 11, 2023

Price History

1W

-0.3%

1M

-0.3%

3M

-3.1%

6M

+0.3%

1Y

+0.3%

3Y

N/A

5Y

N/A

All

-4.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ALFUZOSIN HCL ER 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ALFUZOSIN HCL ER 10 MG TABLET, manufactured by Apotex Corp., is $0.1077 per EA (NDC 60505285009), effective Aug 19, 2026.

How has the price of ALFUZOSIN HCL ER 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for ALFUZOSIN HCL ER 10 MG TABLET has declined 4.9%. It has been tracked across 150 weekly CMS publications since Oct 11, 2023.

What are the highest and lowest recorded NADAC prices for ALFUZOSIN HCL ER 10 MG TABLET?

Since Oct 11, 2023, the NADAC for ALFUZOSIN HCL ER 10 MG TABLET has ranged from a low of $0.1034 (Jan 22, 2025) to a high of $0.1516 (Dec 13, 2023), with a median of $0.1091 per EA.

Are there cheaper alternatives to ALFUZOSIN HCL ER 10 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALFUZOSIN HCL ER 10 MG TABLET, is $0.1074 per EA — about 0% below ALFUZOSIN HCL ER 10 MG TABLET.

Who manufactures ALFUZOSIN HCL ER 10 MG TABLET?

ALFUZOSIN HCL ER 10 MG TABLET (NDC 60505285009) is labeled by Apotex Corp., and CMS classifies it as a generic product.